Editas Medicine (EDIT) Operating Margin (2015 - 2025)
Editas Medicine's (EDIT) quarterly Operating Margin came in at 325.44% in Q3 2025, up 10732374.0% year-on-year from N/an in Q3 2024, and up 77.41% on a QoQ basis from 1440.58% in Q2 2025.
Editas Medicine (EDIT) Operating Margin (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Operating Margin data on file, last reported at 325.44% in Q3 2025.
- On a quarterly basis, Operating Margin rose 10732374.0% year-over-year to 325.44% in Q3 2025; TTM through Sep 2025 was 428.71%, a 5868.0% decrease from a year earlier, with the FY2024 full-year figure at 777.22%, down 56067.0% from the prior year.
- Operating Margin for Q3 2025 stood at 325.44%, up from 1440.58% in the prior quarter.
- Over the last five years, Operating Margin for EDIT reached as high as 39.9% in Q4 2023 and fell as low as 136952.38% in Q3 2022.
- Historically, Operating Margin has averaged 15270.04% across 5 years, with a median of 940.09% in 2023.
- Across the five-year window, Operating Margin plunged 13631896 bps in 2022 and soared 13601229 bps in 2023, its largest moves.
- Year by year, Operating Margin stood at 333.71% in 2021, then sank by 191 bps to 970.72% in 2022, then surged by 96 bps to 39.9% in 2023, then slumped by 282 bps to 152.24% in 2024, then sank by 114 bps to 325.44% in 2025.
- Per Business Quant data, the three most recent Operating Margin figures were 325.44% in Q3 2025, 1440.58% in Q2 2025, and 1635.1% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -325.44% |
| Jun 30, 2025 | -1,440.58% |
| Mar 31, 2025 | -1,635.10% |
| Dec 31, 2024 | -152.24% |
| Sep 30, 2024 | -107,649.18% |
| Jun 30, 2024 | -14,016.18% |
| Mar 31, 2024 | -5,902.29% |
| Dec 31, 2023 | -39.90% |
| Sep 30, 2023 | -940.09% |
| Jun 30, 2023 | -1,527.33% |
| Mar 31, 2023 | -517.32% |
| Dec 31, 2022 | -970.72% |
| Sep 30, 2022 | -136,952.38% |
| Jun 30, 2022 | -852.47% |
| Mar 31, 2022 | -749.52% |
| Dec 31, 2021 | -333.71% |
| Sep 30, 2021 | -633.42% |
| Jun 30, 2021 | -14,617.68% |
| Mar 31, 2021 | -875.26% |
| Dec 31, 2020 | -576.86% |